Michel POLAK
Molecular basis of several congenital or neonatal endocrine disorders and establishment of new therapeutic strategies
Published on 22.10.2025
Presentation
Team
Scientific Publications
-
Journal (source)Lancet Diabetes EndocrinolEffectiveness and safety of the tri-iodothyronine analogue Triac in children ...
-
2019Journal (source)Pediatr Diabetes
Glibenclamide oral suspension: Suitable and effective in patients with neonat...
-
2018Journal (source)EMBO Mol Med
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet ph...
-
Journal (source)Lancet Diabetes Endocrinol
Effectiveness and safety of long-term treatment with sulfonylureas in patient...
-
2018Journal (source)Thyroid
Thyroid Hypoplasia in Congenital Hypothyroidism Associated with Thyroid Perox...
-
2016Journal (source)Hum. Mol. Genet.
Mutations in BOREALIN cause thyroid dysgenesis.
-
Journal (source)Endocrinol. Metab. Clin. North Am.
Update of Thyroid Developmental Genes.
-
2015Journal (source)Diabetes Care
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patie...
-
2014Journal (source)Cell Rep
RFX6 regulates insulin secretion by modulating Ca2+ homeostasis in human β ce...
